EMAIL THIS PAGE TO A FRIEND

Clinical Cancer Research

Trabectedin efficacy in Ewing sarcoma is greatly increased by combination with anti-IGF signaling agents.


PMID 25609059

Abstract

We're sorry this abstract is currently not available.